Revision of Prior Period Financial Statements (Tables)

3 Months Ended

Mar. 31, 2021

Revision Of Prior Period Financial Statements Tabl [Abstract]

Schedule of balance sheet

As of December 23, 2020	As Reported			Adjustment			As Adjusted
Revised Balance Sheet
Warrant Liabilities	$	-		$	574,676		$	574,676
Total Liabilities		-			574,676			574,676
Shares Subject to Possible Redemption		135,094,307			(574,679	)		134,519,628
Common Stock		479			6			485
Additional Paid in Capital		5,007,859			(3	)		5,007,856
Accumulated Deficit		(8,330	)		-			(8,330	)
Total Stockholders’ Equity	$	5,000,008		$	3		$	5,000,011

As of December 31, 2020	As Reported			Adjustment			As Adjusted
Revised Balance Sheet
Warrant Liabilities	$	-		$	580,860		$	580,860
Total Liabilities		303,738			580,860			884,598
Shares Subject to Redemption		134,983,359			(580,871	)		134,402,488
Common Stock		480			6			486
Additional Paid in Capital		5,118,821			6,189			5,125,010
Accumulated Deficit		(119,298	)		(6,184	)		(125,482	)
Total Stockholders’ Equity	$	5,000,003		$	11		$	5,000,014

Schedule of statement of operations

For the Year Ended December 31, 2020	As Reported			Adjustment			As Adjusted
Revised Statement of Operations
Other income (expense):
Change in fair value of warrant liabilities		-			(6,184	)		(6,184	)
Total other income (expense)		3,247			(6,184	)		(2,937	)
Net loss	$	(115,544	)	$	(6,184	)	$	(121,728	)
Weighted average shares outstanding, basic and diluted		4,198,081			-			4,198,081
Basic and diluted net loss per share	$	(0.03	)	$	(0.00	)	$	(0.03	)

Schedule of cash flow

For the Year Ended December 31, 2020	As Reported			Adjustment			As Adjusted
Revised Statement of Cash Flows
Net loss	$	(115,544	)	$	(6,184	)	$	(121,728	)
Adjustments to reconcile net loss to net cash used in operating activities
Change in fair value of warrant liabilities		-			6,184			6,184
Supplemental Non-cash financing activities disclosure
Initial value of warrant liabilities	$	-		$	574,676		$	574,676
Initial value of Common stock subject to possible redemption	$	135,094,307		$	574,679		$	134,519,628
Change in value of Common stock subject to possible redemption	$	(110,948	)	$	(6,192	)	$	(117,140	)